Rapid drug resistance prediction in positive <i>Mycobacterium tuberculosis</i> clinical samples using an extensive targeted next-generation sequencing panel.

Emerg Microbes Infect · 2026 · PMC12903939 · PMID 41631669

Europe PMC DOI

hedged sentence

0.4180

closest p · 8.4× alpha

0.4180

boldest claim

The sentences

showed a trendp = 0.418not close (p > 0.1)

While higher smear positivity showed a trend toward increased coverage ( Figure 3 (A)), the difference was not significant (0 + vs. 3+, p = 0.418).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Rapid drug resistance prediction in positive &lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt; clinical samples using an extensive targeted next-generation sequencing panel.

The sentences

Rapid drug resistance prediction in positive <i>Mycobacterium tuberculosis</i> clinical samples using an extensive targeted next-generation sequencing panel.